ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
139 hedge funds and large institutions have $1.11B invested in Endocyte, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 46 increasing their positions, 32 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
44% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 32
22% more funds holding
Funds holding: 114 → 139 (+25)
Holders
139
Holding in Top 10
8
Calls
$12.6M
Puts
$4.32M
Top Buyers
| 1 | +$37.4M | |
| 2 | +$31.2M | |
| 3 | +$28.5M | |
| 4 |
DM
Deerfield Management
New York
|
+$21.1M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$17.1M |
Top Sellers
| 1 | -$68.1M | |
| 2 | -$11.4M | |
| 3 | -$10.7M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$6.99M |
| 5 |
VMI
VHCP Management II
New York
|
-$1.58M |